Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities

Pacifici, Maurizio

doi:10.1016/j.coph.2018.03.007

Title: Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities

Full Record
Other Related Research

Authors:: Pacifici, Maurizio

Publication Date:: 2018-06-01

Sponsoring Org.:: USDOE

OSTI Identifier:: 1548528

Grant/Contract Number:: W81XWH-07-1-0212; W81XWH-13-2-0076

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Current Opinion in Pharmacology

Additional Journal Information:: Journal Name: Current Opinion in Pharmacology Journal Volume: 40 Journal Issue: C; Journal ID: ISSN 1471-4892

Publisher:: Elsevier

Country of Publication:: Country unknown/Code not available

Language:: English

Citation Formats


                    Pacifici, Maurizio. Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.  Country unknown/Code not available: N. p., 2018. 
Web.  doi:10.1016/j.coph.2018.03.007.

Copy to clipboard


                    Pacifici, Maurizio. Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities.  Country unknown/Code not available.  https://doi.org/10.1016/j.coph.2018.03.007

Copy to clipboard


                    Pacifici, Maurizio. Fri .  
"Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities".  Country unknown/Code not available.  https://doi.org/10.1016/j.coph.2018.03.007.

Copy to clipboard


                    
@article{osti_1548528,

  title        = {Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities},

  author       = {Pacifici, Maurizio},

  abstractNote = {},

  doi          = {10.1016/j.coph.2018.03.007},

  journal      = {Current Opinion in Pharmacology},

  number       = C,

  volume       = 40,

  place        = {Country unknown/Code not available},

  year         = {2018},

  month        = {6}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.coph.2018.03.007

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 16 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

A clinical perspective on common forms of acquired heterotopic ossification

Journal Article Garland, D E - Clinical Orthopaedics and Related Research; (USA)

The clinical courses of heterotopic ossification (HO) as a consequence of trauma and central nervous system insults have many similarities as well as dissimilarities. Detection is commonly noted at two months. The incidence of clinically significant HO is 10%-20%. Approximately 10% of the HO is massive and causes severe restriction in joint motion or ankylosis. The most common sign and symptom are decreased range of motion and pain. The locations are the proximal limbs and joints. Sites of HO about a joint may vary according to the etiology of the HO. Roentgenographic evolution of HO occurs during a six-month periodmore »« less
https://doi.org/10.1097/00003086-199102000-00003
Heterotopic ossification (myositis ossificans) in acquired immune deficiency syndrome. Detection by gallium scintigraphy

Journal Article Drane, W E ; Tipler, B M - Clin. Nucl. Med.; (United States)

A case of heterotopic ossification (myositis ossificans) secondary to the central nervous system complications of acquired immune deficiency syndrome (AIDS) is reported. Because of the overwhelming suspicion of infection in this patient, this diagnosis was not considered until a gallium scan revealed the typical findings of heterotopic ossification. Because of the increasing utilization of gallium imaging in the AIDS population, every imaging specialist should be aware of this potential disorder.
https://doi.org/10.1097/00003072-198706000-00005
A Therapeutic Antibody for Cancer, Derived from Single Human B Cells

Journal Article Bushey, Ryan T. ; Moody, M. Anthony ; Nicely, Nathan L. ; ... - Cell Reports

Some patients with cancer never develop metastasis, and their host response might provide cues for innovative treatment strategies. We previously reported an association between autoantibodies against complement factor H (CFH) and early-stage lung cancer. CFH prevents complement-mediated cytotoxicity (CDC) by inhibiting formation of cell-lytic membrane attack complexes on self-surfaces. In an effort to translate these findings into a biologic therapy for cancer, we isolated and expressed DNA sequences encoding high-affinity human CFH antibodies directly from single, sorted B cells obtained from patients with the antibody. The co-crystal structure of a CFH antibody-target complex shows a conformational change in the targetmore »« less
Cited by 26
https://doi.org/10.1016/j.celrep.2016.04.038
Sensing trace levels of molecular species in solution via zinc oxide nanoprobe Raman spectroscopy

Journal Article Cook, Andrew L. ; Carson, Carcia S. ; Marvinney, Claire E. ; ... - Journal of Raman Spectroscopy

Surface-enhanced Raman spectroscopy (SERS) has potential for unique clinical, environmental, and military applications, among many others, but it is limited by a rapid decrease in signal with distance from the sensing surface. For this reason, much study of SERS-based biosensing involves chemical or physical adsorption of analytes to an active surface. Adsorption, however, limits the types of analytes that can be detected and detection sensitivity. The three-dimensional closely packed architecture of zinc oxide (ZnO) nanowires decorated with silver nanoparticles increases SERS intensity, allowing for adsorption-free biosensing. This approach greatly expands the potential applications of Raman spectroscopy as a biosensing technique.more »« less
Cited by 7
https://doi.org/10.1002/jrs.5180

Full Text Available
Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis

Journal Article Balboni, Tracy A ; Gobezie, Reuben ; Mamon, Harvey J - International Journal of Radiation Oncology, Biology and Physics

Heterotopic ossification (HO) is a benign condition of abnormal formation of bone in soft tissue. HO is frequently asymptomatic, though when it is more severe it typically manifests as decreased range of motion at a nearby joint. HO has been recognized to occur in three distinct contexts-trauma, neurologic injury, and genetic abnormalities. The etiology of HO is incompletely understood. A posited theory is that HO results from the presence of osteoprogenitor cells pathologically induced by an imbalance in local or systemic factors. Individuals at high risk for HO development frequently undergo prophylaxis to prevent HO formation. The two most commonlymore »« less
https://doi.org/10.1016/j.ijrobp.2006.03.053

Similar Records